{"id":"NCT01627327","sponsor":"GlaxoSmithKline","briefTitle":"Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease","officialTitle":"A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once-Daily Via a Novel Dry Powder Inhaler Compared With Tiotropium Bromide Inhalation Powder 18mcg Delivered Once-Daily Via the HandiHaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Who Have or Are at Risk for Co-morbid Cardiovascular Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-04-01","primaryCompletion":"2012-12-01","completion":"2012-12-21","firstPosted":"2012-06-25","resultsPosted":"2013-11-01","lastUpdate":"2017-11-09"},"enrollment":623,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"fluticasone furoate/vilanterol 100/25mcg","otherNames":[]},{"type":"DRUG","name":"tiotropium bromide 18mcg","otherNames":["Spiriva"]}],"arms":[{"label":"fluticasone furoate/vilanterol","type":"EXPERIMENTAL"},{"label":"tiotropium bromide","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the 24-hour spirometry effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg once daily compared with tiotropium bromide inhalation powder 18mcg once daily over a 12-week treatment period in subjects with COPD who have or are at risk for co-morbid cardiovascular disease","primaryOutcome":{"measure":"Change From Baseline Trough in 24-hour Weighted Mean FEV1 on Treatment Day 84","timeFrame":"Baseline and Day 84","effectByArm":[{"arm":"FF/VI 100/25 µg OD","deltaMin":0.117,"sd":0.013},{"arm":"TIO 18 µg OD","deltaMin":0.095,"sd":0.0138}],"pValues":[{"comp":"OG000 vs OG001","p":"0.201"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":16,"exclusionCount":25},"locations":{"siteCount":54,"countries":["United States","Canada","Czechia","Germany","Poland","Romania"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":310},"commonTop":["Headache","Nasopharyngitis"]}}